SEC Form 4 · accession 0000891293-15-000008
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack W Singer
Officer — EVP Global Medical Affairs · Director
Period of report
Feb 27, 2015
Accepted (ET)
Feb 27, 2015 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2015 | S | 14,800 | $2.35 | D | 1,497,689 | D | |
| Common Stock | Feb 27, 2015 | S | 200 | $2.355 | D | 1,497,489 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to a rule 10b5-1 trading plan.